- Active not recruitingPHASE3
A Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy
This study is looking at a new combination medicine, VX-121/TEZ/D-IVA, for people with cystic fibrosis. We want to understand how safe and effective it is over a longer period, especially for those who have been in previous studies with this medication.
For: Cystic FibrosisUnited States · Australia · Austria - Active not recruitingPHASE3
Evaluation of VX-121/Tezacaftor/Deutivacaftor in Cystic Fibrosis (CF) Participants 1 Through 11 Years of Age
This study is testing a new medicine, VX-121/TEZ/D-IVA, for children aged 1 to 11 with cystic fibrosis. We want to see how safe and effective it is, how the body uses it, and if it helps improve their health.
For: Cystic FibrosisUnited States · Australia · Canada